イギリスにおける皮膚置換処置動向

◆英語タイトル:United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020
◆発行会社/調査会社:GlobalData
◆商品コード:GDMECC0860DB
◆発行日:2014年10月15日
◆調査対象地域:イギリス
◆産業分野:医療機器・装置
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[イギリスにおける皮膚置換処置動向]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

United Kingdom Tissue Engineered – Skin Substitutes Market Outlook to 2020

Summary

GlobalData’s new report, “United Kingdom Tissue Engineered – Skin Substitutes Market Outlook to 2020″, provides key market data on the United Kingdom Tissue Engineered – Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments – Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes (Allograft (Cellular and Acellular) and Xenograft Acellular).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered – Skin Substitutes market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size data for Tissue Engineered – Skin Substitutes market segments – Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes.
- Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
- 2013 company shares and distribution shares data for Tissue Engineered – Skin Substitutes market.
- Global corporate-level profiles of key companies operating within the United Kingdom Tissue Engineered – Skin Substitutes.
- Key players covered include Organogenesis, Inc., Smith & Nephew Plc and Molnlycke Health Care AB.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

*** レポート目次(コンテンツ)***

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Tissue Engineered – Skin Substitutes Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Tissue Engineered – Skin Substitutes Market, United Kingdom 7
3.1 Tissue Engineered – Skin Substitutes Market, United Kingdom, Revenue ($m), 2005-2013 7
3.2 Tissue Engineered – Skin Substitutes Market, United Kingdom, Revenue ($m), 2013-2020 9
3.2.1 Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2005-2013 11
3.2.2 Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2013-2020 15
3.3 Tissue Engineered – Skin Substitutes Market, United Kingdom, Volume (Units), 2005-2013 19
3.4 Tissue Engineered – Skin Substitutes Market, United Kingdom, Volume (Units), 2013-2020 21
3.4.1 Biologic Skin Substitutes Market, United Kingdom, Volume (Units), by Segment, 2005-2013 23
3.4.2 Biologic Skin Substitutes Market, United Kingdom, Volume (Units), by Segment, 2013-2020 27
3.5 Tissue Engineered – Skin Substitutes Market, United Kingdom, Average Price ($), 2005-2020 31
3.6 Tissue Engineered – Skin Substitutes Market, United Kingdom, Distribution Share by Revenue ($m), 2012-2013 33
3.7 Tissue Engineered – Skin Substitutes Market, United Kingdom, Company Share by Revenue ($m), 2012-2013 34
4 Overview of Key Companies in United Kingdom, Tissue Engineered – Skin Substitutes Market 36
4.1 Organogenesis, Inc. 36
4.1.1 Company Overview 36
4.2 Smith & Nephew Plc 36
4.2.1 Company Overview 36
4.3 Molnlycke Health Care AB 36
4.3.1 Company Overview 36
4.4 BSN medical GmbH 37
4.4.1 Company Overview 37
4.5 Covidien plc 37
4.5.1 Company Overview 37
5 Appendix 38
5.1 Research Methodology 39
5.1.1 Coverage 39
5.1.2 Secondary Research 39
5.1.3 Primary Research 40
5.1.4 Market Modeling and Forecasting 41
5.1.5 Company Share Analysis 44
5.1.6 Distribution Share Analysis 45
5.2 Expert Panel 45
5.3 GlobalData Consulting 46
5.4 Contact Us 46
5.5 Disclaimer 46

1.1 List of Tables
Table 1: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013 8
Table 2: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020 10
Table 3: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013 12
Table 4: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013 14
Table 5: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020 16
Table 6: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020 18
Table 7: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013 20
Table 8: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020 22
Table 9: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013 24
Table 10: Allograft Market, United Kingdom, Volume (Units), Historic, 2005-2013 26
Table 11: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020 28
Table 12: Allograft Market, United Kingdom, Volume (Units), Forecast, 2013-2020 30
Table 13: Tissue Engineered - Skin Substitutes Market, United Kingdom, Average Price ($), Historic, 2005-2013 31
Table 14: Tissue Engineered - Skin Substitutes Market, United Kingdom, Average Price ($), Forecast, 2013-2020 32
Table 15: Tissue Engineered - Skin Substitutes Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2012-2013 33
Table 16: Tissue Engineered - Skin Substitutes Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2012-2013 35
Table 17: Total Number of Primary Research Participants, Wound Care Management, by Country 41

1.2 List of Figures
Figure 1: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013 7
Figure 2: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020 9
Figure 3: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013 11
Figure 4: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013 13
Figure 5: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020 15
Figure 6: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020 17
Figure 7: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013 19
Figure 8: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020 21
Figure 9: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013 23
Figure 10: Allograft Market, United Kingdom, Volume (Units), Historic, 2005-2013 25
Figure 11: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020 27
Figure 12: Allograft Market, United Kingdom, Volume (Units), Forecast, 2013-2020 29
Figure 13: Tissue Engineered - Skin Substitutes Market, United Kingdom, Company Share (%), 2013 34
Figure 14: GlobalData Epidemiology-Based Forecasting Model 43
Figure 15: GlobalData Capital Equipment-Based Forecasting Model 44
Figure 16: Primary Interviews by Participant Type (%) 45

*** 掲載企業 ***

Organogenesis, Inc.
Smith & Nephew Plc
Molnlycke Health Care AB
BSN medical GmbH
Covidien plc

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDMECC0860DB )"イギリスにおける皮膚置換処置動向" (英文:United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。